|
GPR89A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51114999999979E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88199999998184E-06 |
| Normal-vs-Stage2 |
2.24629999999726E-05 |
| Normal-vs-Stage3 |
1.079540E-03 |
| Normal-vs-Stage4 |
4.166200E-02 |
| Stage1-vs-Stage2 |
8.626800E-01 |
| Stage1-vs-Stage3 |
2.373200E-01 |
| Stage1-vs-Stage4 |
1.216790E-01 |
| Stage2-vs-Stage3 |
3.669400E-01 |
| Stage2-vs-Stage4 |
3.255800E-01 |
| Stage3-vs-Stage4 |
7.164600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95275999999023E-05 |
| Normal-vs-AfricanAmerican |
1.71510000002151E-06 |
| Normal-vs-Asian |
4.258100E-02 |
| Caucasian-vs-AfricanAmerican |
1.385230E-01 |
| Caucasian-vs-Asian |
9.685600E-01 |
| AfricanAmerican-vs-Asian |
8.060000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59100000002499E-06 |
| Normal-vs-Female |
4.00139999999771E-05 |
| Male-vs-Female |
2.472000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88841999999578E-05 |
| Normal-vs-Extreme_Weight |
9.49599999966466E-07 |
| Normal-vs-Obese |
1.67499000000015E-05 |
| Normal-vs-Extreme_Obese |
2.114200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.374400E-01 |
| Normal_Weight-vs-Obese |
9.758200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.300600E-01 |
| Extreme_Weight-vs-Obese |
2.355600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.677600E-01 |
| Obese-vs-Extreme_Obese |
4.105800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.398200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.58558999999725E-05 |
| Normal-vs-Age(61-80Yrs) |
4.48500000005403E-06 |
| Normal-vs-Age(81-100Yrs) |
1.606100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.449000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.045200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.884400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.987600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.870000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.039600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.33490000012671E-07 |
| Normal-VS-Type2 PRCC |
2.623700E-03 |
| Normal-VS-KIRP CIMP |
5.344600E-03 |
| Normal-VS-Unclassified PRCC |
2.46069999998433E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.5279300000004E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.387200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.198200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.441040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.612000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
8.824200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.354620E-04 |
| Normal-vs-N1 |
2.183700E-02 |
| Normal-vs-N2 |
3.284600E-01 |
| N0-vs-N1 |
3.871200E-01 |
| N0-vs-N2 |
4.829600E-01 |
| N1-vs-N2 |
8.258200E-01 |
|
|
